Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05795166
Other study ID # DAS-7530
Secondary ID U1111-1277-8275
Status Completed
Phase
First received
Last updated
Start date April 28, 2023
Est. completion date November 30, 2023

Study information

Verified date April 2024
Source Novo Nordisk A/S
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is intended to understand the distribution of different obesity classes and obesity related diseases (diseases that present along with obesity) in patients with body mass index (BMI) ≥ 30 kg/m^2. Participants will be asked to give information about their health. They will continue their normal way of life and will not get any medication or additional medical test other than those prescribed to you by their doctor. Participation in the study will last for about 1 day.


Recruitment information / eligibility

Status Completed
Enrollment 1241
Est. completion date November 30, 2023
Est. primary completion date April 28, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, age greater than or equal to 18 years at the time of inclusion/enrolment in the study. 3. BMI greater than or equal to 30 Kg/m^2 as measured at the inclusion in the study Exclusion Criteria: 1. Previous participation in this study. Participation is defined as having given informed consent in this study. 2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation as judged by physician.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No treatment given
No treatment given

Locations

Country Name City State
Czechia ADMED s.r.o. Ceske Budejovice
Czechia Ordinace Hradebni s r o Ceske Budejovice
Czechia Poliklinika Chocen a.s. Chocen
Czechia PRAKTIK HRADEK s.r.o. Hradek Nad Nisou
Czechia MUDr Jakub Strincl s r o Liberec
Czechia Res Medica s r o Novy Knin
Czechia Zdravi-fit s.r.o. Praha 5
Czechia Prakticky lekar Vsestary s r o Vsestary
Hungary Dr. Dozsa Katalin Maria EV Biatorbágy
Hungary Dr. Peter Abel Perjes Practice Bicske
Hungary Dr. Torzsa Peter Bt. Budapest
Hungary Family doctors office on Queen Elizabeth Street Budapest
Hungary A & P Kft. Hosszuheteny
Hungary DRC Szentendre Szentendre
Hungary Pecsi Tudomanyegyetem Szentlorinc
Hungary Co-Medi-Catus Kft. Szigethalom
Poland Akademicka Praktyka Medycyny Rodzinnej Bielska Chlabicz Czarnowski Oltarzewska Sawicka Powierza Bialystok
Poland Centrum Medyczne Pratia Bydgoszcz Bydgoszcz
Poland Niepuliczny Zaklad Opieki Zdrowotnej Gizycko
Poland Niepubliczny Zaklad Opieki Zdrowotnej NZOZ ESKULAP s c Koluszki
Poland Bellus Przychodnia Lekarza Rodzinnego Ksiaz Wielkopolski
Poland Aloes sp. z.o. o Lodz
Poland Santa Familia Centrum Badan, Profilaktyki i Leczenia Lodz
Poland Samodzielny Publiczny Szpital kliniczny Nr 4 w Lublinie Lublin
Poland ALLMEDICA sp. z o. o. Nowy Targ
Poland FutureMeds Olsztyn Olsztyn
Poland Clinmedica Research spzo.o Skierniewice
Poland DC-MED Swidnica
Poland ETG Warszawa Warszawa
Poland Przychodnia Vistamed Wroclaw

Sponsors (1)

Lead Sponsor Collaborator
Novo Nordisk A/S

Countries where clinical trial is conducted

Czechia,  Hungary,  Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of patients with at least one obesity related comorbidity of interest for obesity classes I, II and III pooled across all countries % patients with obesity At the time of enrolment (Day 1)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2